정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 751 | Not yet recruiting | Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study) | COVID-19 Vaccination | Biological: BNT162b2 Biological: CoronaVac |
Phase 4 | The University of Hong Kong | OTHER | 400 | All | 18 Years | The University of Hong Kong, Hong Kong, Hong Kong |
| 750 | Recruiting | Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia | Severe COVID-19 Pneumonia | Drug: SOC + IFX-1 Drug: SOC + Placebo |
Phase 3 | InflaRx GmbH | INDUSTRY | 390 | All | 18 Years | University Brussels, Brussels, Belgium University Leuven, Leuven, Belgium Inflarx Site, Yvoir, Belgium Inflarx Site, Campinas, Brazil Inflarx site, Criciuma, Brazil University Porto Alegre, Porto Alegre, Brazil Inflarx Site, Sao Jose, Brazil Hospital Grenoble, Grenoble, France Inflarx Site, Nantes, France University Nantes, Nantes, France University Nice, Nice, France Inflarx Site, Paris, France University Paris 1, Paris, France University Paris 2, Paris, France University Paris 3, Paris, France University St. Etienne, Saint-Etienne, France University Suresnes, Suresnes, France Inflarx Site, Aachen, Germany University Aachen, Aachen, Germany University Augsburg, Augsburg, Germany University Berlin- Charite, Berlin, Germany University Dresden, Dresden, Germany University Greifswald, Greifswald, Germany Inflarx Site, Hannover, Germany Inflarx Site, Jena, Germany University of Chiuhuahua, Chihuahua, Mexico University Culiacan, Culiacan, Mexico University Simon Campos, Merida, Mexico University Nuevo Leon Monterrey, Nuevo Leon, Mexico Inflarx Site, Amsterdam, Netherlands Inflarx, Amsterdam, Netherlands Inflarx site, Eindhoven, Netherlands University Eindhoven, Eindhoven, Netherlands Inflarx Site, Enschede, Netherlands Inflarx Site, Maastricht, Netherlands Inflarx Site, Callao, Peru University Lima II, Lima, Peru University of Peru, Lima, Peru Inflarx Site, Barnaul, Russian Federation University Moscow, Moscow, Russian Federation University Ryazan, Ryazan', Russian Federation University of Somerset West, Somerset West, South Africa |
| 749 | Withdrawn | Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection | Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors | Drug: Hidroxicloroquina Drug: Control group |
Phase 4 | Instituto de Investigacion Marques de Valdecilla | OTHER | 0 | All | 18 Years ~ 75 Years | |
| 748 | Recruiting | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | Community-acquired Pneumonia, Influenza, COVID-19 | Drug: Fixed-duration Hydrocortisone Drug: Shock-dependent hydrocortisone Drug: Ceftriaxone Drug: Moxifloxacin or Levofloxacin Drug: Piperacillin-tazobactam Drug: Ceftaroline Drug: Amoxicillin-clavulanate Drug: Macrolide administered for 3-5 days Drug: Macrolide administered for up to 14 days Drug: Five-days oseltamivir Drug: Ten-days oseltamivir Drug: Lopinavir/ritonavir Drug: Hydroxychloroquine Drug: Hydroxychloroquine + lopinavir/ritonavir Drug: Interferon-β1a Drug: Anakinra Drug: Fixed-duration higher dose Hydrocortisone Drug: Tocilizumab Drug: Sarilumab Drug: Vitamin C Drug: Therapeutic anticoagulation Drug: Simvastatin Biological: Convalescent plasma Other: Protocolised mechanical ventilation strategy Drug: Eritoran Drug: Apremilast Drug: Aspirin Drug: Clopidogrel Drug: Prasugrel Drug: Ticagrelor |
Phase 4 | MJM Bonten, Australian and New Zealand Intensive Care Research Centre, Medical Research Institute of New Zealand, Unity Health, Berry Consultants, Global Coalition for Adaptive Research, University of Pittsburgh Medical Center | OTHER | 7100 | All | 18 Years | University of Pittsburgh Medical Centre, Pittsburgh, Pennsylvania, United States St Vincent's Hospital Sydney, Sydney, New South Wales, Australia Royal Prince Alfred Hospital, Sydney, New South Wales, Australia Royal North Shore Hospital, Sydney, New South Wales, Australia Nepean Hospital, Sydney, New South Wales, Australia Wollongong Hospital, Sydney, New South Wales, Australia Royal Darwin Hospital,, Darwin, Northern Territory, Australia Sunshine Coast University Hospital, Birtinya, Queensland, Australia Princess Alexandra Hospital, Brisbane, Queensland, Australia Logan Hospital, Brisbane, Queensland, Australia Toowoomba Hospital, Toowoomba, Queensland, Australia The Queen Elizabeth Hospital, Adelaide, South Australia, Australia Bendigo Hospital, Bendigo, Victoria, Australia University Hosptial Geelong, Geelong, Victoria, Australia The Alfred Hospital, Melbourne, Victoria, Australia Royal Melbourne Hospital, Melbourne, Victoria, Australia St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia Royal Perth Hospital, Perth, Western Australia, Australia Sir Charles Gairdner Hospital, Perth, Western Australia, Australia St John of God Hospital Midland, Perth, Western Australia, Australia Fiona Stanley Hospital, Perth, Western Australia, Australia St John of God Hospital Murdoch, Perth, Western Australia, Australia AZ Sint-Jan, Brugge, Belgium CHU de Charleroi - Hopital Civil Marie Curie, Charleroi, Belgium Universitair Ziekenhuis Antwerp, Edegem, Belgium Universitair Ziekenhuis Gent, Gent, Belgium St. Joseph's Healthcare Hamilton, Hamilton, Canada Centre Hospitalier de l'Universite de Sherbrooke, Sherbrooke, Canada St. Michael's Hospital Unity Health Toronto, Toronto, Canada General County Hospital Po?ega, Po?ega, Croatia University Hospital Centre Zagreb, Zagreb, Croatia University Hospital for Infectious Diseases, Zagreb, Croatia Charite - Universitatsmedizin Berlin - Infektiologie und Pneumologie, Berlin, Germany Charite - Universitatsmedizin Berlin - Nephrologie, Berlin, Germany Vivantes Klinikum Neukolln, Berlin, Germany Universitatsklinikum Koln, Cologne, Germany Universitatsklinikum Frankfurt, Frankfurt, Germany University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany Medizinische Hochschule Hannover, Hannover, Germany Universitatsklinikum Jena, Jena, Germany Universitatsklinikum Leipzig, Leipzig, Germany Universitats Klinikum Tubingen, Tubingen, Germany Universitatsklinikum Wurzburg, Wurzburg, Germany Josa Andras County Hospital, Nyiregyhaza, Hungary Csolnoky Ferenc Korhaz - Veszprem County Hospital, Veszprem, Hungary Almasi Balogh Pal Korhaz, Ozd, Hungary Beaumont Hospital, Dublin, Ireland St. Vincent's University Hospital, Dublin, Ireland University Hospital Galway, Galway, Ireland Meander Medisch Centrum, Amersfoort, Netherlands Jeroen Bosch Ziekenhuis, Den Bosch, Netherlands Martini Hospital Groningen, Groningen, Netherlands University Medical Center Groningen, Groningen, Netherlands Leiden University Medical Center, Leiden, Netherlands Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands Radboud University Medical Center, Nijmegen, Netherlands University Medical Center Utrecht, Utrecht, Netherlands North Shore Hospital, Auckland, New Zealand CVICU, Auckland City Hospital, Auckland, New Zealand DCCM, Auckland City Hospital, Auckland, New Zealand Middlemore Hospital, Auckland, New Zealand Christchurch Hospital, Christchurch, New Zealand Waikato Hospital, Hamilton, New Zealand Rotorua Hospital, Rotorua, New Zealand Tauranga Hospital, Tauranga, New Zealand Wellington Regional Hospital, Wellington, New Zealand Whangarei Hospital, Whangarei, New Zealand Centro Hospitalar do Medio Tejo, Abrantes, Portugal Hospital Lusiadas Lisbon, Lisboa, Portugal Clinical Hospital of Infectious and Tropical Diseases "Dr. Victor Babes", Bucharest, Romania Institut Hospital del Mar d'Investigacions Mediques, Barcelona, Spain Hospital Universitario Reina Sofia, Cordoba, Spain Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom Southmead Hospital, Bristol, United Kingdom University Hospital Coventry, Coventry, United Kingdom Darlington Memorial Hospital, Darlington, United Kingdom University Hospital of North Durham, Durham, United Kingdom Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom Maidstone Hospital - Maidstone and Tunbridge Wells NHS Trust, Maidstone, United Kingdom The James Cook University Hospital, Middlesbrough, United Kingdom Milton Keynes University Hospital, Milton Keynes, United Kingdom Northampton General Hospital, Northampton, United Kingdom Queen's Medical Centre - Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom Poole Hospital NHS Foundation Trust, Poole, United Kingdom Queen Alexandra Hospital - Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom Royal Berkshire Hospital, Reading, United Kingdom University Hospital of North Tees, Stockton-on-Tees, United Kingdom Royal Cornwall Hospital, Truro, United Kingdom Tunbridge Wells Hospital - Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, United Kingdom York Hospital, York, United Kingdom |
| 747 | Active, not recruiting | Randomized, Unicentric, Open, Controlled Clinical Trial, in Phase Iii, to Demonstrate the Effectiveness of Tocilizumab | COVID-19 Pneumonia | Drug: Tociliziumab group Drug: Methylprednisolone group |
Phase 3 | Asociacion Instituto Biodonostia | OTHER | 60 | Male | 18 Years ~ 99 Years | Clinical Research Platform Biodonostia Health Research Institute, San Sebastian, Guipuzcoa, Spain |
| 746 | Recruiting | Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community | Treatment Efficacy | Drug: FluvoxaMINE Maleate 50 MG Combination Product: Fluvoxamine, Bromhexine Combination Product: Fluvoxamine, Cyproheptadine Drug: Niclosamide Pill Combination Product: Niclosamide, Bromhexine |
Phase 4 | Chulalongkorn University, Rajavithi Hospital, Ministry of Health, Thailand, Mahidol University, Ramathibodi Hospital, QIMR Berghofer Medical Research Institute, Yamagata Prefectural Central Hospital, The University of Western Australia, Mae Fah Luang University, King Chulalongkorn Memorial Hospital, Washington University School of Medicine | OTHER | 1800 | All | 18 Years | Rajvithi Hospital, Ratchathewi, Bangkok, Thailand |
| 745 | Terminated | RAPA-501-Allo Therapy of COVID-19-ARDS | Severe COVID-19 Disease | Biological: RAPA-501-Allo off-the-shelf Therapy of COVID-19 Other: Placebo |
Phase 2 | Rapa Therapeutics LLC, Hackensack Meridian Health | INDUSTRY | 1 | All | 18 Years | Hackensack University Medical Center, Hackensack, New Jersey, United States |
